BMC Gastroenterol

1. GHOLAMHOSSEINZADEH E, Ghalehnoei H, Kazemi Veisari A, Jafari N, et al
   Evaluation of the Rock1 and microRNA-148a expression in biopsies collected from patients with Helicobacter pylori induced gastritis.
   BMC Gastroenterol. 2024;24:251.
   

   >> Share

   
   

   
   Helicobacter

2. MA Y, Zhou X, Liu Y, Xu S, et al
   An Economic Evaluation of Family-Based Versus Traditional Helicobacter pylori Screen-and-Treat Strategy: Based on Real-World Data and Microsimulation Model.
   Helicobacter. 2024;29:e13123.
   

   >> Share

   
   
3. 
   Correction to Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg).
   Helicobacter. 2024;29:e13124.
   

   >> Share

   
   
4. LIU Z, Li H, Huang X, Liu Q, et al
   Animal Models of Helicobacter pylori Infection and Vaccines: Current Status and Future Prospects.
   Helicobacter. 2024;29:e13119.
   

   >> Share

   
   
5. ZHOU S, Zheng Z, Wang L, Song W, et al
   Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection.
   Helicobacter. 2024;29:e13122.
   

   >> Share

   
   
6. ZENG S, Kong Q, Wu X, Ma T, et al
   Artificial Intelligence-Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis.
   Helicobacter. 2024;29:e13115.
   

   >> Share

   
   
7. DING YM, Zhang QM, Li RL, Han ZX, et al
   Tetracycline Three Times Daily Versus Four Times Daily in Bismuth-Containing Quadruple Therapy as the First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial.
   Helicobacter. 2024;29:e13121.
   

   >> Share

   
   

   
   J Gastroenterol Hepatol

8. HAYASAKA J, Hoteya S, Takazawa Y, Kikuchi D, et al
   Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.
   J Gastroenterol Hepatol. 2024;39:1580-1585.
   

   >> Share

   
   
9. LIU J, Yin M, Lv C, Wang W, et al
   Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict proton pump inhibitor response in patients with reflux hypersensitivity.
   J Gastroenterol Hepatol. 2024 Aug 8. doi: 10.1111/jgh.16718.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share